Skip to main content
main-content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2017

13.03.2017 | Original Article – Clinical Oncology

Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation

verfasst von: Xiaohong Chen, Xiaoqiang Ding, Bo Shen, Jie Teng, Jianzhou Zou, Ting Wang, Jian Zhou, Nan Chen, Boheng Zhang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the incidence and outcomes linked with acute kidney injury (AKI) after liver transplantation (LT) in hepatocellular carcinoma (HCC) patients.

Methods

From January 2003 to February 2011, HCC patients undergoing LT were retrospectively enrolled. Patient with a glomerular filtration rate (GFR) <60 mL/min/1.73 m2 was excluded. AKI was defined and classified according to the AKIN criteria.

Results

Of the 566 eligible patients, AKI was found in 109 (19.26%) patients (stage I, 66 cases; stage II, 15 cases; and stage III, 28 cases). Risk factors for AKI were the long anhepatic time (OR = 3.59, P = 0.009) and prolonged duration of systolic blood pressure (SBP) < 90 mmHg (OR = 1.07, P < 0.0001). Post-LT AKI was an independent risk factor associated with 30-day mortality (HR = 4.05, P = 0.047). Complete recovery occurred in 84 (77.06%) of all AKI episodes within 1 month after operation, while 25 patients (22.94%) suffered from prolonged AKI. Patients with prolonged AKI had a poorer 1-year survival than those with transient AKI (40 vs 86.90%; P < 0.0001). Patients with severe AKI more often developed prolonged AKI. 13 patients (52%) of the prolonged AKI progressed to chronic kidney disease (CKD) defined as eGFR <60 mL/min/1.73 m2 after 1 year post-operation.

Conclusions

Post-LT AKI is not an uncommon complication. Intra-operative hemodynamic instability is crucial in the development of post-LT AKI and deserves more attention. Most post-LT AKI is transient and reversible, while the prolonged form may predict a decrease survival.
Literatur
Zurück zum Zitat Barreto AG, Daher EF, Silva GB Jr et al (2015) Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol 14(5): 688–694 PubMed Barreto AG, Daher EF, Silva GB Jr et al (2015) Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol 14(5): 688–694 PubMed
Zurück zum Zitat Caragata R, Wyssusek KH, Kruger P (2016) Acute kidney injury following liver transplantation: a systematic review of published predictive models. Anaesth Intensive Care 44(2):251–261 PubMed Caragata R, Wyssusek KH, Kruger P (2016) Acute kidney injury following liver transplantation: a systematic review of published predictive models. Anaesth Intensive Care 44(2):251–261 PubMed
Zurück zum Zitat Hilmi IA, Damian D, Al-Khafaji A et al (2015) Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth 114(6):919–926. doi: 10.​1093/​bja/​aeu556 CrossRefPubMed Hilmi IA, Damian D, Al-Khafaji A et al (2015) Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth 114(6):919–926. doi: 10.​1093/​bja/​aeu556 CrossRefPubMed
Zurück zum Zitat Lewandowska L, Matuszkiewicz-Rowinska J (2011) Acute kidney injury after procedures of orthotopic liver transplantation. Ann Transplant 16(2):103–108 CrossRefPubMed Lewandowska L, Matuszkiewicz-Rowinska J (2011) Acute kidney injury after procedures of orthotopic liver transplantation. Ann Transplant 16(2):103–108 CrossRefPubMed
Zurück zum Zitat Mehta RL, Cerdá J, Burdmann EA et al (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385(9987):2616–2643. doi: 10.​1016/​S0140-6736(15)60126-X CrossRefPubMed Mehta RL, Cerdá J, Burdmann EA et al (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385(9987):2616–2643. doi: 10.​1016/​S0140-6736(15)60126-X CrossRefPubMed
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 suppl 1):S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 suppl 1):S1–S266
Zurück zum Zitat Starzl TE, Marchioro TL, Vonkaulla KN et al (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117:659–676 PubMedPubMedCentral Starzl TE, Marchioro TL, Vonkaulla KN et al (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117:659–676 PubMedPubMedCentral
Zurück zum Zitat Velidedeoglu E, Crawford MD, Desai NM et al (2002) Predictors of late kidney dysfunction post-liver transplantation. Transplant Proc 34(8):3315–3316 CrossRefPubMed Velidedeoglu E, Crawford MD, Desai NM et al (2002) Predictors of late kidney dysfunction post-liver transplantation. Transplant Proc 34(8):3315–3316 CrossRefPubMed
Zurück zum Zitat Wyssusek KH, Keys AL, Yung J et al (2015) Evaluation of perioperative predictors of acute kidney injury post orthotopic liver transplantation. Anaesth Intensive Care 43(6):757–763 PubMed Wyssusek KH, Keys AL, Yung J et al (2015) Evaluation of perioperative predictors of acute kidney injury post orthotopic liver transplantation. Anaesth Intensive Care 43(6):757–763 PubMed
Zurück zum Zitat Xu X, Ling Q, Wei Q et al (2010) An effective model for predicting acute kidney injury after liver transplantation. Hepatobiliary Pancreat Dis Int 9(3):259–263 PubMed Xu X, Ling Q, Wei Q et al (2010) An effective model for predicting acute kidney injury after liver transplantation. Hepatobiliary Pancreat Dis Int 9(3):259–263 PubMed
Zurück zum Zitat Xue M, Lv C, Chen X et al (2015) Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study. J Diabetes. doi: 10.​1111/​1753-0407.​12356 Xue M, Lv C, Chen X et al (2015) Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study. J Diabetes. doi: 10.​1111/​1753-0407.​12356
Zurück zum Zitat Yu L, Dai Z, Wang Z et al (2011) Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Int Soc Cell 81(suppl 1):116–122. doi: 10.​1159/​000333273 Yu L, Dai Z, Wang Z et al (2011) Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Int Soc Cell 81(suppl 1):116–122. doi: 10.​1159/​000333273
Zurück zum Zitat Zhou J, Fan J, Wu ZQ et al (2005) Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chin Med J (Engl) 118(8):654–659 Zhou J, Fan J, Wu ZQ et al (2005) Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chin Med J (Engl) 118(8):654–659
Metadaten
Titel
Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation
verfasst von
Xiaohong Chen
Xiaoqiang Ding
Bo Shen
Jie Teng
Jianzhou Zou
Ting Wang
Jian Zhou
Nan Chen
Boheng Zhang
Publikationsdatum
13.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2376-8

Weitere Artikel der Ausgabe 7/2017

Journal of Cancer Research and Clinical Oncology 7/2017 Zur Ausgabe

Neu im Fachgebiet Onkologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.